ACTH (4-10) increases quantal content at the mouse neuromuscular junction

Area of Science:

• Neuroscience
• Pharmacology
• Muscle Physiology

Background:

• Neuromuscular transmission is critical for muscle function.
• Adrenocorticotropic hormone fragments are known to modulate neuronal activity.
• Understanding peptide effects on synaptic transmission is key to developing therapeutics.

Purpose of the Study:

• To investigate the effects of Adrenocorticotropic hormone 4-10 (ACTH 4-10) on neuromuscular junctions.
• To determine the specific actions of ACTH 4-10 on synaptic transmission parameters.
• To elucidate the presynaptic or postsynaptic site of action for ACTH 4-10.

Main Methods:

• In vitro electrophysiological recordings from mouse phrenic nerve-diaphragm preparations.
• Stimulation of the phrenic nerve to evoke endplate potentials.
• Application of varying concentrations of ACTH 4-10 (50 nM and 1 microM).
• Analysis of miniature endplate potentials (mEPPs) and endplate potentials (EPPs).

Main Results:

• ACTH 4-10 (50 nM and 1 microM) significantly increased the frequency of miniature endplate potentials.
• ACTH 4-10 increased the amplitude of evoked endplate potentials.
• The number of stimulation failures decreased in the presence of ACTH 4-10.
• No significant effect of ACTH 4-10 on miniature endplate potential amplitude or muscle fiber resting membrane potential was observed.

Conclusions:

• ACTH 4-10 enhances neuromuscular transmission through a presynaptic mechanism.
• The peptide increases the quantal content of the endplate potential, suggesting increased neurotransmitter release.
• ACTH 4-10 does not directly affect the postsynaptic muscle membrane sensitivity.